Obsidian Therapeutics initiated at Outperform by William Blair
William Blair initiated coverage of Obsidian Therapeutics with an Outperform rating, per Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.